Start-up
BioXpress Therapeutics, SA
About BioXpress Therapeutics
BioXpress Therapeutics SA is a privately held biotechnology company committed to developing high quality and cost-competitive biosimilars for unmet need indications such as cancer, inflammation and autoimmunity. Headquartered in Geneva, Switzerland, BioXpress Therapeutics business is focused on developing unbranded monoclonal antibody (MAb and MAb-like) biosimilar under strict European Medicines Agency (EMA) guidelines.
Facts about BioXpress Therapeutics
Facts about BioXpress Therapeutics
- Founding: 2008
- Focus : Service
- Industry : Biotechnology